E-cigarette switching, smoking cessation, and the risk of hepatocellular carcinoma in patients with chronic hepatitis B: A nationwide cohort study in South Korea | Synapse
March 3, 2026
E-cigarette switching, smoking cessation, and the risk of hepatocellular carcinoma in patients with chronic hepatitis B: A nationwide cohort study in South Korea
Key Points
Hepatocellular carcinoma risk correlates with e-cigarette switching behaviors, highlighting significant outcomes in chronic hepatitis B patients.
Patients who switched to e-cigarettes showed differences in smoking cessation rates, impacting hepatocellular carcinoma development.
Utilizing a nationwide cohort, the study analyzed behaviors related to e-cigarette use and smoking cessation effectiveness.
Findings suggest a need for better understanding of e-cigarette impacts on liver cancer risk, especially in chronic disease contexts.